Trademark: 79203359
Word
SANBIO
Status Date
Tuesday, January 16, 2018
Registration Number
5377414
Registration Date
Tuesday, January 16, 2018
Filing Date
Wednesday, October 26, 2016
Published for Opposition
Tuesday, October 31, 2017
5 Pharmaceutical, veterinary preparations and sanitary preparations for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for regenerative medicine for medical purposes; medicines for treating central nervous system diseases; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for regenerative medicine for medical purposes
42 Testing, inspection, research, development and evaluation services for others in the fields of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; consulting services in the field of pharmaceutical research and development; and testing, inspection, research, or development of pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine and medicines for treating central nervous system diseases; conducting clinical trials for others in the field of pharmaceutical products, providing medical and scientific research information in the field of pharmaceutical products, and consulting services in the field of pharmaceutical product research and development; conducting clinical trials for others, providing medical and scientific research information in the field of clinical trials, and consulting services for others in the field of design, planning, and implementation project management of clinical trials; medical research, compiling data for research purposes in the field of medical consultancy, and providing medical research information in the field of pharmaceuticals, gene therapy, cell therapy for medical purposes, regenerative medicine and medicines for treating central nervous system diseases; scientific research and development, scientific research, analysis, and testing in the field of pharmaceutical product development, gene therapy development, cell therapy for medical purposes development, regenerative medicine development and central nervous system diseases therapy development, consulting services in the field of pharmaceutical product research and development, gene therapy research and development, cell therapy for medical purposes research and development, regenerative medicine research and development and central nervous system diseases therapy medicine research and development, and providing scientific research information in the field of pharmaceuticals, gene therapy, cell therapy regenerative medicine and central nervous system diseases therapy medicine
The mark consists of the wording "SANBIO" in black with a light green triangle above the "I"; to the left of the wording is a dark green square with two light green bands inside the square and a third light green band partially outside the square. The color white represents background and is not a feature of the mark.
SAN BIO
The color(s) black, light green and dark green is/are claimed as a feature of the mark.
Oct 24, 2023
Teas Section 71 & 15 Received
Jan 16, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 15, 2018
Final Decision Transaction Processed By Ib
Apr 20, 2018
Final Disposition Notice Sent To Ib
Apr 20, 2018
Final Disposition Processed
Apr 16, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jan 16, 2018
Registered-Principal Register
Oct 31, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2017
Published For Opposition
Oct 29, 2017
Notification Processed By Ib
Oct 11, 2017
Notification Of Possible Opposition Sent To Ib
Oct 11, 2017
Notification Of Notice Of Publication E-Mailed
Oct 11, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 26, 2017
Law Office Publication Review Completed
Sep 25, 2017
Approved For Pub - Principal Register
Sep 25, 2017
Examiner's Amendment Entered
Sep 25, 2017
Notification Of Examiners Amendment E-Mailed
Sep 25, 2017
Examiners Amendment E-Mailed
Sep 25, 2017
Examiners Amendment -Written
Sep 2, 2017
Teas/Email Correspondence Entered
Sep 2, 2017
Correspondence Received In Law Office
Aug 31, 2017
Assigned To Lie
Aug 16, 2017
Teas Voluntary Amendment Received
Aug 15, 2017
Teas Response To Office Action Received
Aug 14, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 14, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 15, 2017
Refusal Processed By Ib
Mar 28, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Mar 28, 2017
Refusal Processed By Mpu
Mar 26, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Mar 25, 2017
Non-Final Action Written
Mar 21, 2017
Application Filing Receipt Mailed
Mar 17, 2017
Assigned To Examiner
Mar 17, 2017
New Application Office Supplied Data Entered
Mar 16, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
